跳转至内容
Merck
CN

V900086

Sigma-Aldrich

硫代乙酰胺

Vetec, reagent grade, 98%

别名:

乙硫酰胺

登录查看公司和协议定价


About This Item

线性分子式:
CH3CSNH2
CAS号:
分子量:
75.13
Beilstein:
506006
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:

等级

reagent grade

产品线

Vetec

方案

98%

mp

108-112 °C (lit.)

官能团

amine

SMILES字符串

CC(N)=S

InChI

1S/C2H5NS/c1-2(3)4/h1H3,(H2,3,4)

InChI key

YUKQRDCYNOVPGJ-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

法律信息

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

象形图

Health hazardExclamation mark

警示用语:

Danger

危险分类

Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Heather Hajovsky et al.
Chemical research in toxicology, 25(9), 1955-1963 (2012-08-08)
The hepatotoxicity of thioacetamide (TA) has been known since 1948. In rats, single doses cause centrolobular necrosis accompanied by increases in plasma transaminases and bilirubin. To elicit these effects, TA requires oxidative bioactivation, leading first to its S-oxide (TASO) and
Hong Ling et al.
PloS one, 8(1), e54499-e54499 (2013-01-26)
Considerable evidence has demonstrated that transforming growth factor β (TGF-β) plays a key role in hepatic fibrosis, the final common pathway for a variety of chronic liver diseases leading to liver insufficiency. Although a few studies have reported that blocking
Suzy M Salama et al.
BMC complementary and alternative medicine, 13, 56-56 (2013-03-19)
Hepatology research has focused on developing traditional therapies as pharmacological medicines to treat liver cirrhosis. Thus, this study evaluated mechanisms of the hepatoprotective activity of Curcuma longa rhizome ethanolic extract (CLRE) on thioacetamide-induced liver cirrhosis in rats. The hepatoprotective effect
Mladen I Yovchev et al.
Hepatology (Baltimore, Md.), 59(1), 284-295 (2013-07-11)
Considerable progress has been made in developing antifibrotic agents and other strategies to treat liver fibrosis; however, significant long-term restoration of functional liver mass has not yet been achieved. Therefore, we investigated whether transplanted hepatic stem/progenitor cells can effectively repopulate
Cun-hua Shao et al.
The Journal of surgical research, 186(1), 408-416 (2013-09-28)
Recent studies have demonstrated that bone marrow-derived mesenchymal stem cells (BM-MSCs) can potentially revert liver fibrosis, but it is not known if preparative hepatic irradiation (HIR) contributes to the therapeutic effect of transplanted BM-MSCs. In this study, we investigate the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门